Shareholders' Deficit (Details 1) - $ / shares		3 Months Ended	12 Months Ended
		Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Beginning Balance Outstanding		4,865,640	4,865,640
Granted
Cancelled or expired		(100,000)
Exercised
Ending Balance Outstanding and exercisable		4,765,640	4,865,640	4,865,640
Weighted Average Exercise Price
Beginning Balance Outstanding		$ 0.84	$ 0.77
Granted
Cancelled or expired		0.20
Ending Balance Outstanding and exercisable		$ 0.84	$ 0.84	$ 0.77
Outstanding and exercisable	[1]	6 months	1 year 6 months	1 year 6 months
Minimum [Member]
Weighted Average Exercise Price
Beginning Balance Outstanding		$ 0.20	$ 0.20
Cancelled or expired		0.20
Ending Balance Outstanding and exercisable		0.89	0.20	$ 0.20
Maximum [Member]
Weighted Average Exercise Price
Beginning Balance Outstanding		1.23	1.23
Cancelled or expired		0.20
Ending Balance Outstanding and exercisable		$ 1.23	$ 1.23	$ 1.23

[1] The aggregate intrinsic value of the 4,765,640 and 4,865,640 outstanding and exercisable warrants at March 31, 2020 and December 31, 2019, respectively, was $0. The intrinsic value is the difference between the closing stock price on March 31, 2020 and December 31, 2019 and the exercise price, multiplied by the number of in-the-money warrants had all warrant holders exercised their warrants on March 31, 2020 and December 31, 2019.